Definitive Contract 75N95020C00025
Award Date 9/18/20
Potential Completion Date 9/20/22
Potential Value $1.5M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92130, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
18
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute on Drug Abuse (NIDA) awarded a $279,863.98 Firm Fixed Price Definitive Contract to S-3 Research LLC, a minority-owned small disadvantaged business, to further develop a proof-of-concept machine learning approach to detect illegal opioid sellers and create a minimum viable product (MVP). This contract is set aside for small businesses. S-3 Research is a data science company that specializes in using big data, machine learning, and data visualization to address public health...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a Small Business Innovation Research (SBIR) Program Phase I contract to B & W TEK Inc., a for-profit manufacturing organization, to develop new commercially viable devices, tools, technologies or integrated systems for drug detection and deactivation to deter opioid theft in hospitals. The definitive, firm fixed-price contract has a potential value of $224,656.02 and a...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $223,874 Small Business Innovation Research (SBIR) Phase I research contract to Medical Decision Logic Inc., a minority-owned, self-certified small disadvantaged business. The contract, which has a firm fixed price, is focused on an unspecified research topic under the SBIR program and has a completion date of March 31, 2020. Medical Decision Logic Inc. has previously provided...
- This is a $1,506,619.84 Phase II Small Business Innovation Research (SBIR) contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS). The contract was awarded to Policy Research Associates, Inc. (PRA), a Woman-Owned Small Business, for research and development related to physical science. The contract has a period of performance from May 2007 to May 2014. PRA has a history of providing technical assistance, support...
- This is a Small Business Innovation Research (SBIR) Phase 1 contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The contract, valued at $279,993.00, was awarded to We The Village, Inc., a for-profit organization, to develop a scalable digital platform for delivering evidence-based training to families to increase treatment admission rates for loved ones with opioid use...
- This is a base award to Scitech Strategies Inc., a small business, under the SBIR (Small Business Innovation Research) Program Phase I of the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The award is for the creation of an accurate model of the topical structure of PubMed and associated indicators. The contract has a firm fixed price of $225,000.00 for a period of performance from...
- <p>This is a $1,128,083.26 Small Business Innovation Research (SBIR) Phase II contract awarded by the National Institute on Drug Abuse (NIDA), a civilian federal agency, to J G Perpich LIMITED Liability Company. The contract is for the development of an "INTERACTIVE WEB-BASED NETWORKING TOOL F/LINKING SERVICES & INTERVENTIONS" under SBIR Topic 44. The contract has a cost-plus-fixed-fee pricing type and a final completion date of May 2, 2014.</p>
- This is a Cost Plus Fixed Fee contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Medavante, Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase II. The contract, valued at $625,055.25, is for research and development in physical science. The contract has a period of performance through September 16, 2011. This contract is a definitive contract, indicating it is a stand-alone award rather than being associated with a larger...
- This is a $301,970.00 Small Business Innovation Research (SBIR) Phase I base award contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to What A Smoke L.L.C. for the development and characterization of an FDA-compliant electronic vapor-based combination product. The period of performance is from September 15, 2015 to May 14, 2016, and the contract is a Firm Fixed Price Definitive Contract. There is no indication that this award is associated with a larger contract...
- <p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $2,451,736.00 cost-plus-fixed-fee contract to Medispin Inc., a small business, for R&D in physical science. The 3-year contract (ultimate completion date of Nov 30, 2009) was awarded on Sep 22, 2006 under a total small business set-aside. The contract is for research and experimental development activities related to the agency's mission.</p>
S-3 Research LLC has been awarded a $1.5 million firm fixed price contract by the National Institutes of Health's National Institute on Drug Abuse to further develop and commercialize a minimum viable product originally created under Phase I of the Small Business Innovation Research program. Over the next two years, the company will focus on four technical objectives to expand its product offering and successfully bring the Phase I technology to market. The award is designated for total small business participation. As the lead agency for substance abuse and addiction research, the National Institute on Drug Abuse seeks to support innovative solutions through programs like SBIR that can help address public health challenges.
Generated 12/29/23, 3:27 PM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Nanoparticle Delivery of HIV Env Trimer for Inducing Somatic Hypermutation and bNAb | PHS-2019-1 | Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases | Award Notice 1/1 | 6/29/18, 8:32 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Other Administrative Action | $0 | 10/12/21 | |
| P00001 | Other Administrative Action | $0 | 11/5/20 | |
| Not listed | Not listed | $1.5m | 9/18/20 |